292 related articles for article (PubMed ID: 25105438)
1. Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada.
Cressman S; Lam S; Tammemagi MC; Evans WK; Leighl NB; Regier DA; Bolbocean C; Shepherd FA; Tsao MS; Manos D; Liu G; Atkar-Khattra S; Cromwell I; Johnston MR; Mayo JR; McWilliams A; Couture C; English JC; Goffin J; Hwang DM; Puksa S; Roberts H; Tremblay A; MacEachern P; Burrowes P; Bhatia R; Finley RJ; Goss GD; Nicholas G; Seely JM; Sekhon HS; Yee J; Amjadi K; Cutz JC; Ionescu DN; Yasufuku K; Martel S; Soghrati K; Sin DD; Tan WC; Urbanski S; Xu Z; Peacock SJ;
J Thorac Oncol; 2014 Oct; 9(10):1449-58. PubMed ID: 25105438
[TBL] [Abstract][Full Text] [Related]
2. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
[TBL] [Abstract][Full Text] [Related]
3. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
[TBL] [Abstract][Full Text] [Related]
4. Current estimate of costs of lung cancer screening in the United States.
Mauchley DC; Mitchell JD
Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.
Goulart BH; Bensink ME; Mummy DG; Ramsey SD
J Natl Compr Canc Netw; 2012 Feb; 10(2):267-75. PubMed ID: 22308519
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
Kowada A
BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of lung MRI in lung cancer screening.
Allen BD; Schiebler ML; Sommer G; Kauczor HU; Biederer J; Kruser TJ; Carr JC; Hazen G
Eur Radiol; 2020 Mar; 30(3):1738-1746. PubMed ID: 31748855
[TBL] [Abstract][Full Text] [Related]
9. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Lung Cancer Screening in Canada.
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
[TBL] [Abstract][Full Text] [Related]
11. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
12. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
14. Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.
Gareen IF; Black WC; Tosteson TD; Wang Q; Sicks JD; Tosteson ANA
Med Care; 2018 May; 56(5):403-409. PubMed ID: 29613874
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review.
Puggina A; Broumas A; Ricciardi W; Boccia S
Eur J Public Health; 2016 Feb; 26(1):168-75. PubMed ID: 26370440
[TBL] [Abstract][Full Text] [Related]
16. Long-term Oncologic and financial implications of lung cancer screening.
Pedersen JH; Sørensen JB
Thorac Surg Clin; 2015 May; 25(2):223-9. PubMed ID: 25901566
[TBL] [Abstract][Full Text] [Related]
17. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience.
Shmueli A; Fraifeld S; Peretz T; Gutfeld O; Gips M; Sosna J; Shaham D
Value Health; 2013; 16(6):922-31. PubMed ID: 24041342
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
[TBL] [Abstract][Full Text] [Related]
20. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.
Goulart BH; Ramsey SD
Oncologist; 2013; 18(8):941-6. PubMed ID: 23873718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
